Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple endocrine neoplasia type 1
Comorbidity C0011854|type 1 diabetes mellitus
Sentences 2
PubMedID- 19703761 Background and aims: once-daily (od) basal insulin glargine (gla) can be used as part of a multiple daily injection regimen in patients with type 1 diabetes mellitus.
PubMedID- 25143741 Idegasp provides similar, noninferior glycemic control to a standard basal-bolus regimen in patients with type 1 diabetes mellitus, with additional benefits of significantly lower episodes of hypoglycemia (particularly nocturnal) and fewer daily insulin injections.

Page: 1